52
Participants
Start Date
October 31, 2012
Primary Completion Date
April 30, 2013
Study Completion Date
May 31, 2013
Placebo
Capsule, appears identical with udenafil, will be provided by Dong-A pharmaceutical company. Patients will receive 50 mg of placebo drug two times a day for 4 weeks, and then the dosage will be escalated to 100 mg two times a day for next 8 weeks.
Udenafil (Zydena)
Udenafil (Zydena), a newly developed PDE-5 inhibitor by Dong-A pharmaceutical company, will be administered to patients in this group, 50 mg two times a day for 4 weeks, and then the dosage will be escalated to 100 mg two times a day for next 8 weeks.
RECRUITING
Seoul National University Bundang Hospital, Seongnam-si
RECRUITING
Seoul National University Hospital, Seoul
Collaborators (1)
Dong-A Pharmaceutical Co., Ltd.
INDUSTRY
Seoul National University Bundang Hospital
OTHER
Seoul National University Hospital
OTHER